头颈部癌症患者吞咽困难风险的咳嗽评估概述。
Assessment of cough in head and neck cancer patients at risk for dysphagia-An overview.
机构信息
Department of Radiation Oncology, Speech Therapy, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Department of Otolaryngology and Head and Neck Surgery, University Rehabilitation Center for Communication Disorders, Antwerp University Hospital, Antwerp, Belgium.
出版信息
Cancer Rep (Hoboken). 2021 Oct;4(5):e1395. doi: 10.1002/cnr2.1395. Epub 2021 May 1.
BACKGROUND
This literature review explores the terminology, the neurophysiology, and the assessment of cough in general, in the framework of dysphagia and regarding head and neck cancer patients at risk for dysphagia. In the dysphagic population, cough is currently assessed perceptually during a clinical swallowing evaluation or aerodynamically.
RECENT FINDINGS
Recent findings have shown intra and inter-rater disagreements regarding perceptual scoring of cough. Also, aerodynamic measurements are impractical in a routine bedside assessment. Coughing, however, is considered to be a clinically relevant sign of aspiration and dysphagia in head and cancer patients treated with concurrent chemoradiotherapy.
CONCLUSION
This article surveys the literature regarding the established cough assessment and stresses the need to implement innovative methods for assessing cough in head and neck cancer patients treated with concurrent chemoradiotherapy at risk for dysphagia.
背景
本文献综述探讨了在吞咽困难的背景下，以及针对有吞咽困难风险的头颈部癌症患者，咳嗽的术语、神经生理学和评估。在吞咽困难人群中，目前通过临床吞咽评估或气动评估来感知性评估咳嗽。
新发现
最近的研究结果表明，在感知性咳嗽评分方面，存在观察者内和观察者间的不一致。此外，气动测量在常规床边评估中不切实际。然而，在接受同步放化疗治疗的头颈部癌症患者中，咳嗽被认为是一种与吸入和吞咽困难相关的临床相关征象。
结论
本文综述了关于既定咳嗽评估的文献，并强调需要为接受同步放化疗治疗的有吞咽困难风险的头颈部癌症患者开发评估咳嗽的创新方法。
Zotero 插件